ARVO 2024: A study on multi-ingredient oral supplement for dry eye symptoms and tear volume David Hutton;Martin David Harp May 8th 2024 Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington, from May 5 to May 9, on a multi-ingredient ...
为贯彻落实中山大学2024年春季工作会议精神,以高水平对外交流合作助推中山眼科中心高质量发展“123总部署”及“1411具体要求”落地见效,推进实现“全面建成世界一流眼科中心”目标,2024年5月5日-5月9日,中山眼科中心师生团队赴美国西雅图参加2024年...
我听到了一些令人振奋的研究成果,比如接触镜设计创新,联合矫正手段在近视防控的应用,这些研究为我们提供了近视防控手段的选择,也为近视人群带来了更多希望。 Poster展示环节,让我们在询问及讨论过程中,结识来自不同国家和地区的同行,并与他们...
Hi, I'm Barry Kuppermann, director of the Gavin Herbert Eye Institute at the University of California Irvine. I'm here at ARVO Seattle 2024. [I'll] be presenting a poster coming up tomorrow on the EyePoint technology. That's a biodegradable polymer that stores and releases vorolanib, wh...
The programme includes thousands of poster and paper presentations by up-and-coming vision scientists and world leaders in their respective subspecialties.
Presentation Number / Posterboard Number: 6097 - B0943 Abstract Title: Safety and expression following subretinal administration of AAV.ABCA4.intein vectors in the non-human primate retina Session Number: 515 Session Title: Gene and cell thera...
Poster Presentation details: Presentation Number - Posterboard Number:5956 - A0021 Abstract Title: GLP safety study of intein-based Dual AAV8.ABCA4 for Stargardt Disease Session Number: 534 Session Title: G...
Poster Number: B0521 Session: 148 April 25 8:45 AM to 10:30 AM CDT Susvimo Port delivery system with ranibizumab in the treatment of diabetic retinopathy without center-involved diabetic macular edema: primary analysis results of the Phase 3 Pavili...
陆方 教授:关于ROP的治疗,会议上北京大学人民医院程湧教授以POSTER形式汇报了抗VEGF药物康柏西普与激光光凝治疗的研究对比,结果证实二者都是非常有效的ROP治疗手段,康柏西普安全有效、长期并发症风险低,证据确凿,深受临床医患信任。自2021年国际上重新定义了ROP分类后,其检查方式与治疗手段都发生了较大的改变,抗VEGF治疗...
ARVO 2024: Imaging provides insight into the metabolic aspects of glaucoma development Martin David Harp;David Hutton May 7th 2024 Osamah Saeedi, MD, MS, discusses his poster presentation from the ARVO Imaging in the Eye conference ARVO 2024: Children with CVI experience lower vision-specific qualit...